Clinical Trial Update: Named Patient Program With Certolizumab Pegol in Adults Suffering From Rheumatoid Aarthritis (RA)

View source ↗

Summary

This document updates a named patient program for certolizumab pegol in adults with rheumatoid arthritis, sponsored by UCB Biopharma SRL, and notes that the pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CIMZIA (CERTOLIZUMAB PEGOL)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Rheumatoid Arthritis | Status: AVAILABLE